3/4
08:31 am
mtva
MetaVia to Highlight Novel Obesity and Metabolic Therapies at Upcoming Life Sciences Virtual Investor Forum
Medium
Report
MetaVia to Highlight Novel Obesity and Metabolic Therapies at Upcoming Life Sciences Virtual Investor Forum
2/17
09:01 am
mtva
MetaVia to Highlight Novel Obesity and Metabolic Therapies at Upcoming Emerging Growth Conference
Medium
Report
MetaVia to Highlight Novel Obesity and Metabolic Therapies at Upcoming Emerging Growth Conference
2/13
08:31 am
mtva
MetaVia Builds Comprehensive Global Patent Protection for DA-1726, Securing Exclusive Rights to Novel Obesity and Metabolic Therapy Through 2041
High
Report
MetaVia Builds Comprehensive Global Patent Protection for DA-1726, Securing Exclusive Rights to Novel Obesity and Metabolic Therapy Through 2041
2/4
08:13 am
mtva
MetaVia Announces Positive AI-Modeling Results from its Ongoing Syntekabio Collaboration, Confirming Key Therapeutic Targets for Vanoglipel [Yahoo! Finance]
Medium
Report
MetaVia Announces Positive AI-Modeling Results from its Ongoing Syntekabio Collaboration, Confirming Key Therapeutic Targets for Vanoglipel [Yahoo! Finance]
2/4
08:00 am
mtva
MetaVia Announces Positive AI-Modeling Results from its Ongoing Syntekabio Collaboration, Confirming Key Therapeutic Targets for Vanoglipel
Medium
Report
MetaVia Announces Positive AI-Modeling Results from its Ongoing Syntekabio Collaboration, Confirming Key Therapeutic Targets for Vanoglipel
1/16
04:01 pm
mtva
MetaVia Announces the Closing of $9.3 Million Underwritten Public Offering, Including Full Exercise of Allotment Option
Medium
Report
MetaVia Announces the Closing of $9.3 Million Underwritten Public Offering, Including Full Exercise of Allotment Option
1/15
09:32 am
mtva
MetaVia Announces the Pricing of $8.1 Million Underwritten Public Offering
High
Report
MetaVia Announces the Pricing of $8.1 Million Underwritten Public Offering
1/6
01:30 pm
mtva
MetaVia (NASDAQ:MTVA) had its price target raised by analysts at HC Wainwright from $12.00 to $40.00. They now have a "buy" rating on the stock.
Low
Report
MetaVia (NASDAQ:MTVA) had its price target raised by analysts at HC Wainwright from $12.00 to $40.00. They now have a "buy" rating on the stock.
1/27
04:02 pm
mtva
Form 4 MetaVia Inc. For: Jan 23 Filed by: Woodworth Marshall H
High
Report
Form 4 MetaVia Inc. For: Jan 23 Filed by: Woodworth Marshall H
1/27
04:02 pm
mtva
Form 8-K MetaVia Inc. For: Jan 23
High
Report
Form 8-K MetaVia Inc. For: Jan 23
1/27
04:01 pm
mtva
Form 4 MetaVia Inc. For: Jan 23 Filed by: Kim Hyung Heon
High
Report
Form 4 MetaVia Inc. For: Jan 23 Filed by: Kim Hyung Heon
1/16
04:05 pm
mtva
Form 8-K MetaVia Inc. For: Jan 15
Medium
Report
Form 8-K MetaVia Inc. For: Jan 15
1/16
08:37 am
mtva
Form 424B4 MetaVia Inc.
High
Report
Form 424B4 MetaVia Inc.
1/16
06:03 am
mtva
Form EFFECT MetaVia Inc.
Medium
Report
Form EFFECT MetaVia Inc.
1/15
09:13 am
mtva
Form S-1MEF MetaVia Inc.
High
Report
Form S-1MEF MetaVia Inc.
1/12
05:22 pm
mtva
Form S-1/A MetaVia Inc.
Low
Report
Form S-1/A MetaVia Inc.
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register